These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10155196)

  • 1. Troubleshooting new ICD systems.
    Lindsay BD
    J Interv Cardiol; 1994 Oct; 7(5):473-85. PubMed ID: 10155196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection.
    Shivkumar K; Feliciano Z; Boyle NG; Wiener I
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1285-8. PubMed ID: 11083251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations and late complications of third-generation automatic cardioverter-defibrillators.
    Nunain SO; Roelke M; Trouton T; Osswald S; Kim YH; Sosa-Suarez G; Brooks DR; McGovern B; Guy M; Torchiana DF
    Circulation; 1995 Apr; 91(8):2204-13. PubMed ID: 7697850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced ICD troubleshooting: Part I.
    Swerdlow CD; Friedman PA
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1322-46. PubMed ID: 16403166
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICD-antiarrhythmic drug and ICD-pacemaker interactions.
    Brode SE; Schwartzman D; Callans DJ; Gottlieb CD; Marchlinski FE
    J Cardiovasc Electrophysiol; 1997 Jul; 8(7):830-42. PubMed ID: 9255691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden Death in Patients With Cardiac Implantable Electronic Devices.
    Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E
    JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalemia induced T wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks.
    Koul AK; Keller S; Clancy JF; Lampert R; Batsford WP; Rosenfeld LE
    Pacing Clin Electrophysiol; 2004 May; 27(5):681-3. PubMed ID: 15125731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous implantable cardioverter-defibrillator technology.
    Gupta A; Al-Ahmad A; Wang PJ
    Heart Fail Clin; 2011 Apr; 7(2):287-94, x. PubMed ID: 21439506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defribrillator shocks: a troubleshooting guide.
    Swerdlow CD; Zhang J
    Rev Cardiovasc Med; 2001; 2(2):61-72. PubMed ID: 12439383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP;
    Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of ICD implant testing.
    Swerdlow CD; Russo AM; Degroot PJ
    Pacing Clin Electrophysiol; 2007 May; 30(5):675-700. PubMed ID: 17461879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining antiarrhythmic drugs and implantable devices therapy: benefits and outcome.
    Santini M; Pandozi C; Ricci R
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():65-8. PubMed ID: 10590491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.